Evidence map›Paper›PMID 38021466›Full record

ArticleMaterials advances2023

One-step simultaneous liquid phase exfoliation-induced chirality in graphene and their chirality-mediated microRNA delivery.

Pranav, Eswara N H K Ghali, Neeraj Chauhan, Rahul Tiwari, Marco Cabrera, Subhash C Chauhan, Murali M Yallapu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

PranavDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley McAllen TX USA murali.yallapu@utrgv.edu +1 956-296-1734.
Eswara N H K GhaliDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley McAllen TX USA murali.yallapu@utrgv.edu +1 956-296-1734.
Neeraj ChauhanDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley McAllen TX USA murali.yallapu@utrgv.edu +1 956-296-1734.
Rahul TiwariDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley McAllen TX USA murali.yallapu@utrgv.edu +1 956-296-1734.
Marco CabreraDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley McAllen TX USA murali.yallapu@utrgv.edu +1 956-296-1734.
Subhash C ChauhanDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley McAllen TX USA murali.yallapu@utrgv.edu +1 956-296-1734.
Murali M YallapuDepartment of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley McAllen TX USA murali.yallapu@utrgv.edu +1 956-296-1734.ORCID https://orcid.org/0000-0002-0073-8828
The University of Texas Rio Grande Valley · US

Funding

miR-205 Nanoparticle system circumvents docetaxel resistance in prostate cancerSC1GM139727 · NIGMS · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI YALLAPU, MURALI MOHAN · 2021 to 2024
$1.5M
NIGMS NIH HHS SC1 GM139727
6 · The paper itself

Abstract

Graphene (G) has established itself as an exciting prospect for a broad range of applications owing to its remarkable properties. Recent innovations in chiral nanosystems have led to sensors, drug delivery, catalysis,

Identifiers

PMID38021466
PMCPMC10680132
OpenAlexW4387350157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.